Biliary Lithiasis and Obesity

  • Mario Rizzello
  • Giovanni Casella
  • Francesca Abbatini
  • Gianfranço Silecchia
  • Nicola Basso


Gallbladder stones are a common clinical finding in the Western population: a prevalence rate of 10–15% in adult European and of 3–5% in African and Asian populations has been reported. In several Western countries 80% of gallstones are cholesterol stones in a matrix of bile pigments calcium salts and glycoproteins [1, 2, 3, 4, 5]. Adut age, female gender, fecundity and family history of gallstone disease are strongly associated with the formation of cholesterol stones. Moreover, specific dietetic regimens, such as high cholesterol and high carbohydrate diets, are associated with an increased risk of gallstone formation [6]. Obesity (body mass index BMI>30 kg/m2), and other factors contributing to the metabolic syndrome, such as dyslipidemia, hyperinsulinemia, insulin resistance or type 2 diabetes, are also well established risk factors.


Bariatric Surgery Obese Patient Gastric Bypass Laparoscopic Cholecystectomy Ursodeoxycholic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Marschall HU, Einarsson C (2007) Gallstone disease. J Intern Med 261:529–542PubMedCrossRefGoogle Scholar
  2. 2.
    Kratzer W, Mason RA, Kachele V (1999) Prevalence of gallstones in sonographic surveys world-wide. J Clin Ultrasound 27:1–7PubMedCrossRefGoogle Scholar
  3. 3.
    Everhart JE, Khare M, Hill M et al (1999) Prevalence and ethnic difference in gallbladder disease in the United States. Gastroenterology 117:632–639PubMedCrossRefGoogle Scholar
  4. 4.
    Sampliner RE, Bennett PH, Comess LJ et al (1970) Gallbladder disease in Pima Indians. Demonstration of high prevalence and early onset by cholecystography. N Engl J Med 283:1358–1364PubMedGoogle Scholar
  5. 5.
    Everhart JE, Yeh F, Lee ET et al (2002) Prevalence of gallbladder disease in American Indian populations: findings from the Strong Heart Study. Hepatology 35:1507–1512PubMedCrossRefGoogle Scholar
  6. 6.
    EA Shaffer (2006) Epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol 20:981–996PubMedCrossRefGoogle Scholar
  7. 7.
    Wang SN, Yeh YT, Yu ML et al (2006) Hyperleptinaemia and hypoadiponectinaemia are associated with gallstone disease. Eur J Clin Invest 36:176–180PubMedCrossRefGoogle Scholar
  8. 8.
    Trayhurn P, Wood IS (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92:347–355PubMedCrossRefGoogle Scholar
  9. 9.
    Friedman GD, Kamel WB, Dawber TR (1996) The epidemiology of gallbladder disease: observations in the Framingham study. J Chronic Dis 19:273–292CrossRefGoogle Scholar
  10. 10.
    Amaral JF, Thompson WR (1985) Gallbladder disease in the morbidly of obese. Am J Surg 149:551–557PubMedCrossRefGoogle Scholar
  11. 11.
    Aidonopoulos AP, Papavramidis ST, Zaraboukas TG et al (1994) Gallbladder findings after cholecystectomy in morbidly obese patients. Obes Surg 4:8–12PubMedCrossRefGoogle Scholar
  12. 12.
    Calhoun RC, Willbanks O (1987) Coexistence of gallbladder disease and morbid obesity. Am J Surg 154:665–658CrossRefGoogle Scholar
  13. 13.
    Fobi M, Lee H, Igwe D et al (2002) Prophylactic cholecystectomy with gastric bypass operation: incidence of gallbladder disease. Obes Surg 12:350–353PubMedCrossRefGoogle Scholar
  14. 14.
    Hamad GG, Ikramuddin S, Gourash WF et al (2003) Elective cholecystetomy during laparoscopic Roux-en-Y gastric bypass: is it worth the wait? Obes Surg 13:76–81PubMedCrossRefGoogle Scholar
  15. 15.
    Zhang Y, Proenca R, Maffei M et al (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372:425–432PubMedCrossRefGoogle Scholar
  16. 16.
    Friedman JM, Halaas JL (1998) Leptin and the regulation of body weight in mammals. Nature 395:763–770PubMedCrossRefGoogle Scholar
  17. 17.
    VanPatten S, Ranginani N, Shefer S et al (2001) Impaired biliary lipid secretion in obese Zucker rats: leptin promotes hepatic cholesterol clearance. Am J Physiol Gastrointest Liver Physiol 281:393–404Google Scholar
  18. 18.
    Hyogo H, Roy S, Paigen B et al (2002) Leptin promotes biliary cholesterol elimination during weight loss in ob/ob mice by regulating the enterohepatic circulation of bile salts. J Biol Chem 277:117–124CrossRefGoogle Scholar
  19. 19.
    Tran KQ, Sartz-Basile DA, Nakeeb A et al (2003) Gallbladder motility in agouti-yellow and leptin-resistant obese mice. J Surg Res 113:56–61PubMedCrossRefGoogle Scholar
  20. 20.
    Graewin SJ, Kiely JM, Lee KH et al (2004) Nonobese diabetic mice have diminished gallbladder motility and shortened crystal observation time. J Gastrointest Surg 8:824–829PubMedCrossRefGoogle Scholar
  21. 21.
    Graewin SJ, Lee KH, Kiely JM et al (2004) Gallbladder myocytes are short and cholecystokinin-resistant in o bese diabetic mice. Surgery 136:431–436PubMedCrossRefGoogle Scholar
  22. 22.
    Tsai CJ, Leitzmann MF, Willett WC et al (2005) Glycemic load, glycemic index, and carbohydrate intake in relation to risk of cholecystectomy in women. Gastroenterology 129:105–112PubMedCrossRefGoogle Scholar
  23. 23.
    Sasazuki S, Kono S, Todoroki I et al (1999) Impaired glucose tolerance, diabetes mellitus, and gallstone disease: and extended study of male self-defense officials in Japan. Eur J Epidemio 15:245–251CrossRefGoogle Scholar
  24. 24.
    Papavramidis S, Deligianidis N, Papavramidis T et al (2003) Laparoscopic cholecystectomy after bariatric surgery. Surg Endosc 17:1061–1064PubMedCrossRefGoogle Scholar
  25. 25.
    Jiffry BO, Shaffer EA, Saccone GTP et al (2003) Changes in gallbladder motility and gallstone formation following laparoscopic gastric banding for morbid obesity. Can J Gastroenterol 17:169–174Google Scholar
  26. 26.
    Erlinger S (2000) Gallstones in obesity and weight loss. Eur J Gastroenterol Hepatol 12:1347–1352PubMedCrossRefGoogle Scholar
  27. 27.
    Shiffman ML, Kaplan GD, Brinkman-Kaplan V et al (1995) Prophylaxis against gallstone formation with ursodeoxycholic acid in patients participating in a very-low-calorie diet program. Ann Int Med 122:899–905PubMedGoogle Scholar
  28. 28.
    Shiffman ML, Sugerman HJ, Kellum JM et al (1991) Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity. Am J Gastroenterol 86:1000–1005PubMedGoogle Scholar
  29. 29.
    Shiffman ML, Sugerman HJ, Kellum JM et al (1993) Gallstones in patients with morbid obesity: relationship to body weight, weight loss and gallbladder bile cholesterol solubility. Int J Obes 17:153–158Google Scholar
  30. 30.
    Worobetz LJ, Inglis FG, Shaffer EA (1993) The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss. Am J Gastroenterol 88:1705–1710PubMedGoogle Scholar
  31. 31.
    Kiewiet RM, Durian MF, van Leersum M et al (2006) Gallstone formation after weight loss following gastric banding in morbidly obese Dutch patients. Obes Surg 16(5):592–596PubMedCrossRefGoogle Scholar
  32. 32.
    Miller K, Hell E, Lang B et al (2003) Gallstone formation prophylaxis after gastric restrictive procedures for weight loss. Ann Surg 238:697–702PubMedCrossRefGoogle Scholar
  33. 33.
    Shiffman ML, Sugerman HJ, Kellum JM et al (1991) Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity. Am J Gastroenterol 86:1000–1005PubMedGoogle Scholar
  34. 34.
    Scopinaro N, Gianetta E, Civalleri D (1979) Biliopancreatic bypass for obesity II Initial experience in man. Br J Surg 66:618–620PubMedCrossRefGoogle Scholar
  35. 35.
    Scopinaro N, Gianetta E, Civalleri D et al (1980) Two years experience with bilio-pancreatic bypass. Am J Clin Nutr 33:506–514PubMedGoogle Scholar
  36. 36.
    Bardaro SJ, Gagnér M, Consten E et al (2004) Is routine cholecystectomy during bilio pancreatic diversion with duodenal switch really necessary? Abstract ASBS, San DiegoGoogle Scholar
  37. 37.
    Hess DS, Hess DW (1998) Biliopancreatic diversion with a duodenal switch. Obes Surg 8:267–282PubMedCrossRefGoogle Scholar
  38. 38.
    Friedman GD (1993) Natural history of asymptomatic and symptomatic gallstones. Am J Surg 165:399–404PubMedCrossRefGoogle Scholar
  39. 39.
    Attili AF, De Santis A, Capri R et al (1995) The natural history of gallstones: the GREPCO experience. Hepatology 21:655–660PubMedCrossRefGoogle Scholar
  40. 40.
    Alponat A, Kun CK, Koh BC (1997) Predictive factors for conversion of laparoscopic cholecystectomy. World J Surg 21:629–633PubMedCrossRefGoogle Scholar
  41. 41.
    Sidhu RS, Raj PK, Treat RC (2007) Obesity as a factor in laparoscopic holecystectomy. Surg Endosc 21:774–776PubMedCrossRefGoogle Scholar
  42. 42.
    Simopoulos C, Polychronidis A, Botaitis S (2005) Laparoscopic cholecystectomy in obese patients. Obes Surg 15:243–246PubMedCrossRefGoogle Scholar
  43. 43.
    Westling A, Bergqvist D et al (2002) Incidence of deep venous thrombosis in patients undergoing obesity surgery. World J Surg 26:470–473PubMedCrossRefGoogle Scholar
  44. 44.
    Fakhry SM, Herbst CA, Buckwalter JA (1987) Cholecystectomy in morbidly obese patients. Am Surg 53:26–28PubMedGoogle Scholar
  45. 45.
    Jones KB Jr (1995) Simultaneous cholecystectomy: to be or not to be. Obes Surg 5:52–54PubMedCrossRefGoogle Scholar
  46. 46.
    Mason E, Renquist KE (2002) Gallbladder management in obesity surgery Obes surg 12:222–229PubMedCrossRefGoogle Scholar
  47. 47.
    Scott DJ, Villegas L, Sims TL et al (2003) Intraoperative ultrasound and prophylactic ursodiol for gallstone prevention following laparoscopic gastric bypass. Surg Endosc 17:1796–802PubMedCrossRefGoogle Scholar
  48. 48.
    Angrisani L, Lorenzo M, De Palma G et al (1995) Laparoscopic cholecystectomy in obese patients compared with nonobese patients. Surgical Laparose Endosc 5:197–201Google Scholar
  49. 49.
    Sugerman HJ, Brewer WH, Shiffman ML et al (1995) A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric bypass-induced rapid weight loss. Am J Surg 169:91–97PubMedCrossRefGoogle Scholar
  50. 50.
    Martinez J, Guerrero L, Byers P et al (2006) Endoscopic retrograde cholangiopancreatography and gastroduodenoscopy after Roux-en-Y gastric bypass. Surg Endosc 20(10):1548–1550PubMedCrossRefGoogle Scholar
  51. 51.
    Goitein D, Gagn DJ, Papasavas PK et al (2006) Percutaneous computed tomography-guided gastric remnant access after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis 2(6):651–655PubMedCrossRefGoogle Scholar
  52. 52.
    Fobi M, Lee H, Igwe D (2002) Prophylactric cholecystectomy with gastric bypass operation: incidence of gallbladder disease. Obes Surg 12(3):350–353PubMedCrossRefGoogle Scholar
  53. 53.
    Ross AS, Semrad C, Alverdy J et al (2006) Use of double-balloon enteroscopy to perform PEG in the excluded stomach after Roux-en-Y gastric bypass. Gastrointest Endosc 64(5):797–800PubMedCrossRefGoogle Scholar
  54. 54.
    Ceppa FA, Gagne DJ, Papasavas PK et al (2007) Laparoscopic transgastric endoscopy after Rouxen-Y gastric bypass Surg Obes Relat Dis 3(1):21–24PubMedCrossRefGoogle Scholar
  55. 55.
    Mutignani M, Marchese M, Tringali A et al (2007) Laparoscopy-assisted ERCP after biliopancreatic diversion. O bes Surg 17(2):251–254Google Scholar

Copyright information

© Springer-Verlag Italia 2008

Authors and Affiliations

  • Mario Rizzello
    • 1
  • Giovanni Casella
    • 1
  • Francesca Abbatini
    • 1
  • Gianfranço Silecchia
    • 1
  • Nicola Basso
    • 1
  1. 1.Department of Surgery P. Stefanini Policlinico Umberto IUniversity of Rome La SapienzaRomeItaly

Personalised recommendations